DJIA 17,976.31 263.65 1.49%
NASDAQ 4,947.44 56.22 1.15%
S&P 500 2,086.24 25.22 1.22%
market minute promo


21.09 0.59 (2.88%)

REAL-TIME: Last trade at

Extended Hours: $21.09 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

INSM $21.09 2.88%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $20.76
Previous Close $20.50
Daily Range $20.39 - $21.32
52-Week Range $11.25 - $22.59
Market Cap $1.1B
P/E Ratio -11.14
Dividend (Yield) $0.00 (0.0%)
Volume 606,919
Average Daily Volume 572,233
Current FY EPS -$2.07




Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

5 Red-Hot Biotech Stocks to Buy

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape

Markets Rise; Macy's Lowers Comparable Sales Outlook

Markets Rise; Macy's Lowers Comparable Sales Outlook

Benzinga's Volume Movers

See More INSM News...

INSM's Top Competitors

INSM $21.09 (2.88%)
Current stock: INSM
AMGN $164.31 (1.05%)
Current stock: AMGN
GILD $100.69 (-0.31%)
Current stock: GILD
BIIB $431.62 (0.41%)
Current stock: BIIB